Protagonist Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. Thanks for joining us for another session at the forty-fourth JPMorgan Healthcare Conference. I'm Brian Cheng. I'm the senior biotech Analyst here at the firm. On stage, we have the CEO of Protagonist Therapeutics, Dinash Patel. Now, I'll now pass the mic to their CEO, Dinash, for a short presentation, followed by a live audience Q&A. Dinash, the stage is yours.
Excellent. Good morning, everybody, and thank you, Brian, for the kind introductions. It's a real privilege for the protagonists to participate at this prestigious conference, and this is for the 6th year in a row now.
Just a quick reminder that we will be making forward-looking statements during the presentation and throughout the conference.
So this slide, provides an outline of today's talk, and it also highlights how the next 12 to 24 months are going to be a phase of immense growth and value creation that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
